MORPHIC HOLDING, INC.

Profile

Company Names

MORPHIC HOLDING, INC.
MORPHIC HOLDING, LLC

Addresses

35 GATEHOUSE DRIVE A2, WALTHAM, MA 02451

Phone Numbers

9787296480

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$200,599,744.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-02-15 
$99,999,755.00 
$100,000,000.00 
$245.00 
Equity 
2
2018-09-17 
$79,999,990.00 
$79,999,990.00 
$0.00 
Equity 
1
2016-06-29 
$20,599,999.00 
$51,500,000.00 
$30,900,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NORBERT 
 
BISCHOFBERGER 
DIRECTOR
REZO THERAPEUTICS, INC.   |  MORPHIC HOLDING, INC.
KEVIN 
 
BITTERMAN 
DIRECTOR
PARASOL THERAPEUTICS INC   |  TARIS BIOMEDICAL INC   |  BIOLEX THERAPEUTICS, INC.   |  FOLLICA, INC   |  VISTERRA, INC.   |  KALA PHARMACEUTICALS, INC.   |  GENOCEA BIOSCIENCES, INC.   |  NEURONETICS, INC.   |  DIRECT VET MARKETING, INC.   |  EDITAS MEDICINE, INC.   |  MORPHIC HOLDING, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  NAVITOR PHARMACEUTICALS, INC.   |  AKERO THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  KINASET THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  JUDO BIO INC.   |  CHROMA MEDICINE, INC.   |  REMIX THERAPEUTICS, INC.   |  GRO BIOSCIENCES INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  RENASANT BIO, INC.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
GUSTAV 
 
CHRISTENSEN 
DIRECTOR
MORPHIC HOLDING, LLC   |  GENERATION BIO CO.   |  MORPHIC HOLDING, INC.
BARBARA 
 
DALTON 
DIRECTOR
CELLADON CORP   |  CYDAN, LLC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  IMARA INC.   |  MORPHIC HOLDING, LLC   |  COMPLEXA INC.   |  CYDAN II, INC.   |  MAGNOLIA NEUROSCIENCES CORP
WILLIAM 
 
DEVAUL 
EXECUTIVE OFFICER
EVELO BIOSCIENCES, INC.   |  MORPHIC HOLDING, INC.
MARTIN 
 
EDWARDS 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  TARSA THERAPEUTICS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  HARMONY BIOSCIENCES II, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  INOZYME PHARMA, INC.   |  VERONA PHARMA PLC   |  MORPHIC HOLDING, INC.
RAMY 
 
FARID 
DIRECTOR
NIMBUS DISCOVERY, LLC   |  SCHRODINGER, INC.   |  MORPHIC HOLDING, LLC   |  AJAX THERAPEUTICS, INC.   |  SHOUTI INC.
ROBERT 
 
FARRELL 
EXECUTIVE OFFICER
AMARANTUS BIOSCIENCE HOLDINGS, INC.   |  MORPHIC HOLDING, LLC   |  KALYTERA THERAPEUTICS, INC.   |  RTS HOLDING, INC.
ROBERT 
E. 
FARRELL 
EXECUTIVE OFFICER
MORPHIC HOLDING, INC.
VIKAS 
 
GOYAL 
DIRECTOR
CALCIMEDICA INC   |  MACROLIDE PHARMACEUTICALS, INC.   |  MORPHIC HOLDING, LLC   |  SPERO THERAPEUTICS, LLC   |  PANDION THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC
SUSANNAH 
 
GRAY 
DIRECTOR
MORPHIC HOLDING, INC.
NILESH 
 
KUMAR 
DIRECTOR
AUXOGYN INC   |  AUXOGYN, INC.   |  TARVEDA THERAPEUTICS, INC.   |  RGENIX, INC.   |  CIRIUS THERAPEUTICS, INC.   |  MILESTONE PHARMACEUTICALS INC.   |  MORPHIC HOLDING, LLC
ALEXEY 
A. 
LUGOVSKOY 
EXECUTIVE OFFICER
MORPHIC HOLDING, LLC
NISHA 
 
NANDA 
DIRECTOR
MORPHIC HOLDING, INC.
AMIR 
 
NASHAT 
DIRECTOR
PROMEDIOR INC   |  AVILA THERAPEUTICS INC   |  PERVASIS THERAPEUTICS INC   |  FATE THERAPEUTICS INC   |  BIND BIOSCIENCES INC   |  SELECTA BIOSCIENCES INC   |  POLARIS VENTURE PARTNERS VI, L.P.   |  SUN CATALYTIX CORP   |  RECEPTOS, INC.   |  POLARIS ENTREPRENEURS- FUND VII, L.P.   |  POLARIS PARTNERS VII, L.P.   |  ATYR PHARMA INC   |  AGBIOME, LLC   |  METACRINE, INC.   |  SCHOLAR ROCK LLC   |  1366 TECHNOLOGIES INC   |  SOFREGEN MEDICAL INC.   |  POLARIS ENTREPRENEURS- FUND VIII, L.P.   |  SYROS PHARMACEUTICALS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  CAMP4 THERAPEUTICS CORP   |  MORPHIC HOLDING, LLC   |  FREENOME HOLDINGS, INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  MORPHIC HOLDING, INC.
BRUCE 
 
ROGERS 
EXECUTIVE OFFICER
MEDTECH GROUP HOLDINGS, INC.   |  VENTION MEDICAL, INC.   |  VENTION MEDICAL HOLDINGS, INC.   |  HS2 HOLDINGS, LP   |  ELITE SEM HOLDINGS, LP   |  MORPHIC HOLDING, LLC   |  MERITDIRECT HOLDINGS, LP   |  RELEVATE HOLDINGS, LP   |  ACCELERATION PARTNERS PARENT, LP   |  BIODERM HOLDINGS, LP   |  MORPHIC HOLDING, INC.   |  BOND BRAND PARENT, LLC
MARC 
 
SCHEGERIN 
EXECUTIVE OFFICER
MORPHIC HOLDING, INC.
JOSEPH 
P. 
SLATTERY 
DIRECTOR
MORPHIC HOLDING, INC.
TIMOTHY 
 
SPRINGER 
DIRECTOR
SCHOLAR ROCK LLC   |  MORPHIC HOLDING, LLC   |  SELECTA BIOSCIENCES INC   |  LEVEL ACCESS HOLDINGS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  CARTESIAN THERAPEUTICS, INC.   |  TECTONIC THERAPEUTIC, INC.
TIMOTHY 
A. 
SPRINGER 
DIRECTOR
TECTONIC THERAPEUTIC, INC.   |  MORPHIC HOLDING, INC.   |  SEISMIC THERAPEUTIC, INC.   |  CARTESIAN THERAPEUTICS, INC.
OTELLO 
 
STAMPACCHIA 
DIRECTOR
OMEGA FUND III, L.P.   |  OMEGA FUND II, L.P.   |  TREVI THERAPEUTICS, INC.   |  MORPHIC HOLDING, LLC   |  ESSA PHARMA INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SCORPION THERAPEUTICS, INC.   |  IKENA ONCOLOGY, INC.   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
PRAVEEN 
P. 
TIPIRNENI 
EXECUTIVE OFFICER, DIRECTOR
MORPHIC HOLDING, INC.   |  TECTONIC THERAPEUTIC, INC.
PRAVEEN 
 
TIPRIRNENI 
EXECUTIVE OFFICER, DIRECTOR
MORPHIC HOLDING, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-03-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-02-15 
2018-10-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-17 
2016-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#